Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ChIP-seq]

ABSTRACT: To get insight into the histone modification in the transcriptional dysregulation of NSC aging, we profiled the principal regulatory histone marks at the promoters and enhancers of age-dependent genes using ChIP-sequencing.

ORGANISM(S): Mus musculus

PROVIDER: GSE214978 | GEO | 2023/11/02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging.

Project description:To study the role of MLL complex in transcriptional dysregulation of NSC aging, we performed ChIP-seq of MLL complex subunits (Kmt2d, Rbbp5, and Wdr5) and Cbx3 in young and aged NSCs to analyze their binding activity at promoters of age-dependent genes.

2023-11-02 | GSE223781 | GEO

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ATAC-seq]

Project description:To examine whether chromatin accessibility is associated with transcription of age-dependent genes in NSC aging, we profiled the chromatin accessibility at the promoters and enhancers of age-dependent genes using the assay for transposase-accessible chromatin with sequencing (ATAC-seq).

2023-11-02 | GSE214971 | GEO

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging.

Project description:Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging.

| PRJNA928369 | ENA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [RNA-seq]

Project description:Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [RNA-seq]

| PRJNA877008 | ENA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ATAC-seq]

Project description:Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ATAC-seq]

| PRJNA887809 | ENA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ChIP-seq]

Project description:Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [ChIP-seq]

| PRJNA887822 | ENA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [scRNA-seq]

Project description:Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [scRNA-seq]

| PRJNA877033 | ENA

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [RNA-seq]

Project description:To identify age-dependent genes of NSCs, we applied bulk RNA sequencing to profile the transcriptomic changes between the young and aged NSCs that were isolated from the brain SVZ.

2023-11-02 | GSE212724 | GEO

Transcriptional dysregulation impairs efficacy of neural stem cell activation during aging [scRNA-seq]

Project description:To gain insight of the decreasing activation efficacy in the aging NSCs, we performed single-cell transcriptomics analysis using the Chromium Single Cell 3’ platform (10x Genomics).

2023-11-02 | GSE212723 | GEO

Histone deacetylation-dependent and -independent transcriptional dysregulation in early-onset polyglutamine disease

Project description:Transcriptional dysregulation is an important early feature of polyglutamine diseases. One of its proposed causes is defective neuronal histone acetylation, but important aspects of this hypothesis, such as the precise genomic topography of acetylation deficits and the relationship between transcriptional and acetylation alterations at the whole-genome level, remain unknown. The new techniques for the mapping of histone posttranslational modifications at genomic scale enable such global analyses and are challenging important assumptions concerning the role of specific histone modifications in gene expression. We examined here the genome-wide correlation of histone acetylation and gene expression defects in a mouse model of early-onset Huntington’s disease. Our analyses identified hundreds of loci that were hypoacetylated for H3K9,14 and H4K12 in the chromatin of these mice. Surprisingly, few genes with altered transcript levels in mutant mice showed significant changes in these acetylation marks and vice versa. Our screen, however, identified a subset of genes in which H3K9,14 deacetylation and transcriptional dysregulation concur. Genes in this group were consistently affected in different brain areas, mouse models and tissue from patients, which suggests a role in the etiology of this pathology. Overall, the combination of histone acetylation and gene expression screenings demonstrates that histone deacetylation and transcriptional dysregulation are two early, largely independent, manifestations of polyglutamine disease and suggests that additional epigenetic marks or mechanisms are required for explaining the full range of transcriptional alterations associated with this disorder. Examination of 2 different histone modifications in the hippocampus of wild-type and HD mice (PrP-htt-N171-82Q (Schilling et al., 1999)). Samples were obtained from 10 week old mice.

2013-06-20 | E-GEOD-44854 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data